Found: 7
Select item for more details and to access through your institution.
Optimizing antibody expression by using the naturally occurring framework diversity in a live bacterial antibody display system.
- Published in:
- Scientific Reports, 2015, v. 5, n. 1, p. 17488, doi. 10.1038/srep17488
- By:
- Publication type:
- Article
Tethered-variable C<sub>L</sub> bispecific IgG: an antibody platform for rapid bispecific antibody screening.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2017, v. 30, n. 9, p. 627, doi. 10.1093/protein/gzx034
- By:
- Publication type:
- Article
Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 463, p. 1, doi. 10.1126/scitranslmed.aat5775
- By:
- Publication type:
- Article
The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation.
- Published in:
- Nature Structural & Molecular Biology, 2009, v. 16, n. 12, p. 1279, doi. 10.1038/nsmb.1700
- By:
- Publication type:
- Article
Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 8, p. 753, doi. 10.1038/nbt.2621
- By:
- Publication type:
- Article
The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions.
- Published in:
- Nature Cell Biology, 2006, v. 8, n. 10, p. 1155, doi. 10.1038/ncb1477
- By:
- Publication type:
- Article
Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 5, p. 970, doi. 10.3390/pharmaceutics14050970
- By:
- Publication type:
- Article